Yongkang Nuoao Trading CoTirzepatide
Ordered Tirzepatide from Yongkang Nuoao Trading Co? Mail in a sample (US only) and let us test it for free.
Test my supplyYongkang Nuoao tirzepatide is mainly limited by an Oct 2025 purity miss at 99.12%; an early -27% fill result is a separate caveat. Later 2026 tests passed identity, purity, and fill, but batch IDs and price/review signals are absent.
We investigated who actually operates Yongkang Nuoao Trading Co — corporate records, ownership trails, web infrastructure, and how its lab results break down product by product. Read the full report before you order.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Yongkang Nuoao Trading Co rows.
Cancel anytime
About Yongkang Nuoao Trading Co test results from Finnrick
Yongkang Nuoao Trading Co is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 3 peptides and 16 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Yongkang Nuoao Trading Co peptides in this dataset are Retatrutide (8 tests), Tesamorelin (3 tests) and Tirzepatide (5 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 16 recent tests.
Ordered Tirzepatide from Yongkang Nuoao Trading Co? Mail in a sample (US only) and let us test it for free.
Test my supply